Structural differences between foot-and-mouth disease and poliomyelitis viruses influence their inactivation by

T Burrage1, E Kramer, F Brown

  • 1USDA, ARS, Plum Island Animal Disease Center, Greenport, NY, USA.

Vaccine
|March 30, 2000
PubMed

Insights

Ethyleneimine (EI) and N-acetylethyleneimine (AEI) inactivate foot-and-mouth disease virus (FMDV) and poliovirus. Poliovirus inactivation by AEI depends on temperature and ionic strength, linked to changes in particle diameter.

Area of Science:

  • Virology
  • Biochemistry
  • Structural Biology

Background:

  • Foot-and-mouth disease virus (FMDV) and poliovirus are significant human and animal pathogens.
  • Ethyleneimine (EI) and N-acetylethyleneimine (AEI) are chemical agents with potential virucidal applications.
  • Understanding virus inactivation mechanisms is crucial for developing effective antiviral strategies.

Purpose of the Study:

  • To investigate the inactivation kinetics of FMDV and poliovirus by EI and AEI under varying temperature and ionic conditions.
  • To elucidate the structural basis for differential inactivation rates, particularly for poliovirus.
  • To correlate virus particle structural changes with inactivation susceptibility.

Main Methods:

  • Virus inactivation assays were performed using FMDV and poliovirus treated with EI and AEI at 25°C and 37°C in different Tris buffer concentrations (1 mM, 10 mM, 100 mM).
  • Electron microscopy (phosphotungstic acid staining) was employed to visualize virus particle morphology and measure particle diameter.
  • Reversibility of structural changes was assessed by altering buffer ionic strength.

Main Results:

  • FMDV was rapidly inactivated by both EI and AEI under all tested conditions.
  • Poliovirus inactivation by EI was rapid, but inactivation by AEI was temperature and ionic strength-dependent.
  • Electron microscopy revealed that poliovirus particle diameter increased with decreasing ionic strength and increasing temperature, correlating with enhanced AEI penetrability and inactivation. FMDV showed less sensitivity to ionic strength changes.

Conclusions:

  • Poliovirus structural integrity, specifically particle diameter, is sensitive to temperature and ionic strength, influencing its susceptibility to AEI inactivation.
  • AEI inactivation of poliovirus is facilitated by increased particle permeability at higher temperatures and lower ionic strengths.
  • FMDV exhibits greater structural stability and is less affected by osmotic variations compared to poliovirus.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...